Miho Takami

751 citations
18 papers · 600 indexed · h-index 10
Topics
Pluripotent Stem Cells Research (5 papers)Lymphatic System and Diseases (5 papers)Platelet Disorders and Treatments (4 papers)
Partner nations
JapanChinaUnited States

In The Last Decade

Miho Takami

17 papers receiving 596 citations

Peers

Miho Takami
Comparison fields: 5 of 57
  • Oncology 412
  • Molecular Biology 246
  • Surgery 121
  • Immunology 102
  • Hematology 90
Replace Ai Takemoto with:
Ai Takemoto Japan
Caroline Wallace United States
Monika Haemmerle Germany
Masahiko Zuka Japan
Brett H. Herzog United States
Beth A. Markens United States
Alona Merkulova United States
Léa Plantureux France
Elizabeth Masse United States
Maksim Yezhelyev Germany
Miho Takami relative to Ai Takemoto Japan Ai Takemoto's profile →
Citations per field
00.5×2.9×
Ai Takemoto · 1×
Citations per year

Countries citing papers authored by Miho Takami

Since Specialization
Citations

This map shows the geographic impact of Miho Takami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Takami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Takami more than expected).

Fields of papers citing papers by Miho Takami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Takami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Takami. The network helps show where Miho Takami may publish in the future.

Co-authorship network of co-authors of Miho Takami

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Takami. A scholar is included among the top collaborators of Miho Takami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Takami. Miho Takami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 10
3 19
4 5
5 4
6 3
7 7
8 8
9 6
10 98
11 69
12 74
13 10
14 170
15 35
16 48
17 28
18
[Establishment of metastatic sub-clone from estrogen independent Ishikawa cells and its characterization in vitro and in vivo].
6

About Miho Takami

Miho Takami is a scholar working on Hematology, Oncology and Molecular Biology, having authored 18 papers that have together received 600 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (5 papers), Lymphatic System and Diseases (5 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Oncology (412 citations), Hematology (90 citations) and Internal Medicine (29 citations). Miho Takami has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Naoya Fujita, Satoshi Takagi, Shigeo Sato, Tomoko Oh‐hara, Ai Takemoto, Sumie Koike, Yuji Mishima, Kiyohiko Hatake, Sakae Okumura and Makoto Nishio. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026